Cortavance is a veterinary medicine used to treat inflamed and itchy skin conditions in dogs. It is also used to treat symptoms of itchy skin in dogs prone to allergies (atopic dermatitis). Cortavance contains the active substance hydrocortisone aceponate.
Cortavance : EPAR - Medicine overview (PDF/119.54 KB)
First published: 02/08/2007
Last updated: 24/09/2021
|Agency product number||
|International non-proprietary name (INN) or common name||
|Anatomical therapeutic chemical veterinary (ATCvet) codes||
|Date of issue of marketing authorisation valid throughout the European Union||
1ère Avenue 2065 M - L.I.D.
20/04/2021 Cortavance - EMEA/V/C/000110 - II/0015
This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.
Corticosteroids, dermatological preparations
For symptomatic treatment of inflammatory and pruritic dermatoses in dogs.
For alleviation of clinical signs associated with atopic dermatitis in dogs.
Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 16-18 March 202119/03/2021
Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 8-10 December 202011/12/2020